Millions Around World To Observe Rare Disease Day PDF Print E-mail
Saturday, 19 February 2011 08:20
Millions Around World To Observe Rare Disease Day
The Relief Foundation will be joining the National Organization for Rare Disorders (NORD) and others around the world in observing World Rare Disease Day on February 28, 2011.  On this day, millions of patients and their families will share their stories to focus a spotlight on rare diseases as an important global public health concern.
“There are nearly 30 million Americans—and millions more around the world—affected by rare diseases,” said Peter L. Saltonstall, president and CEO of NORD.  “Everyone knows someone with a rare disease.  But, while many of these diseases are serious and lifelong, most have no treatment and many are not even being studied by researchers.  Insurance cost for treatment of rare diseases is very expensive and cost prohibitive.  Also, payments for the treatment of rare diseases is often denied by most insurance plans which leaves patients and families without hope for a better future.”
A rare disease is one that affects fewer than 200,000 Americans.  There are nearly 7,000 such diseases affecting nearly 30 million Americans.
World Rare Disease Day was launched in Europe four years ago and last year was observed in 46 nations.  It is always observed on the last day of February.  On that day, patients and patient organizations will post stories, videos and blogs online and host events to raise awareness of these diseases, which are often called “orphans”.
The Relief Foundation represents patients and families affected by Scleroderma.  Scleroderma (skleer-oh-DUR-muh) comes from two Greek words: “sclero” meaning hard, and “derma” meaning skin.  Scleroderma is a chronic autoimmune disorder which means the body's tissues are attacked by its own immune system.  In the simplest of terms, Scleroderma is an overproduction of collagen that can result in thickening or tightening of skin and scarring of internal organs.
Scleroderma is rare and it is estimated by several sources that about 300,000 Americans suffer from this debilitating disease.  Although it’s more common in women between the ages of 25 and 55, the disease also occurs in men and children.  The cause of Scleroderma is unknown and it affects people of all races and ethnic groups.
The Relief Foundation was founded out of a need to provide access to information, tools and people who can bolster the quality of life for individuals living with Scleroderma. Thus, our mission is to be a resource and support organization dedicated to promoting public awareness and providing Relief to people living with Scleroderma and their families.
The Relief Foundation awareness event will be hosted by Lew Prince and Vintage Vinyl at 6610 Delmar Blvd, St. Louis, MO  63130 on Rare Disease Day between 11:00am–1:00pm.  The event will include poster displays, the distribution of fliers, RDD merchandise give-a-ways, a raffle and culminating with a balloon release.
In the U.S., the coalition supporting Rare Disease Day includes patient organizations and advocacy groups, medial professionals and associations, government agencies, researchers, and companies developing treatments for rare diseases.
For more information contact:
Kelly J. Ellison, The Relief Foundation
Founder and President
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
www.relief-foundation.org
314-497-0040
or visit www.rarediseaseday.us. for information about Rare Disease Day events in the U.S.
The Relief Foundation will be joining the National Organization for Rare Disorders (NORD) and others around the world in observing World Rare Disease Day on February 28, 2011.  On this day, millions of patients and their families will share their stories to focus a spotlight on rare diseases as an important global public health concern.

“There are nearly 30 million Americans—and millions more around the world—affected by rare diseases,” said Peter L. Saltonstall, president and CEO of NORD.  “Everyone knows someone with a rare disease. But, while many of these diseases are serious and lifelong, most have no treatment and many are not even being studied by researchers.  Insurance cost for treatment of rare diseases is very expensive and cost prohibitive.  Also, payments for the treatment of rare diseases is often denied by most insurance plans which leaves patients and families without hope for a better future.”

A rare disease is one that affects fewer than 200,000 Americans.  There are nearly 7,000 such diseases affecting nearly 30 million Americans.

World Rare Disease Day was launched in Europe four years ago and last year was observed in 46 nations.  It is always observed on the last day of February.  On that day, patients and patient organizations will post stories, videos and blogs online and host events to raise awareness of these diseases, which are often called “orphans”.

The Relief Foundation represents patients and families affected by Scleroderma.  Scleroderma (skleer-oh-DUR-muh) comes from two Greek words: “sclero” meaning hard, and “derma” meaning skin.  Scleroderma is a chronic autoimmune disorder which means the body's tissues are attacked by its own immune system.  In the simplest of terms, Scleroderma is an overproduction of collagen that can result in thickening or tightening of skin and scarring of internal organs. 

Scleroderma is rare and it is estimated by several sources that about 300,000 Americans suffer from this debilitating disease.  Although it’s more common in women between the ages of 25 and 55, the disease also occurs in men and children.  The cause of Scleroderma is unknown and it affects people of all races and ethnic groups.

The Relief Foundation was founded out of a need to provide access to information, tools and people who can bolster the quality of life for individuals living with Scleroderma. Thus, our mission is to be a resource and support organization dedicated to promoting public awareness and providing Relief to people living with Scleroderma and their families.

The Relief Foundation awareness event will be hosted by Lew Prince and Vintage Vinyl at 6610 Delmar Blvd, St. Louis, MO  63130 on Rare Disease Day between 11:00am–1:00pm.  The event will include poster displays, the distribution of fliers, RDD merchandise give-a-ways, a raffle and culminating with a balloon release.

In the U.S., the coalition supporting Rare Disease Day includes patient organizations and advocacy groups, medial professionals and associations, government agencies, researchers, and companies developing treatments for rare diseases.
For more information contact:
 
Kelly J. Ellison, The Relief Foundation
Founder and President
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
www.relief-foundation.org
314-497-0040
or visit www.rarediseaseday.us. for information about Rare Disease Day events in the U.S.

 
More articles :

» Our Donors

The Scleroderma Care Foundation wishes to express our appreciation and gratitude for the generosity and support extended to us, by all of our donors to date, and the list keeps on growing. Your contributions have all been incredibly helpful and...

» Unite Against Scleroderma 2012

For our second year running, the Scleroderma Care Foundation will be hosting its “Unite Against Scleroderma” Awareness Walk around the , Port of Spain. Scheduled to start from 3:00pm, the Walk would be held on Sunday May 6th 2012 and cover one...

» Researchers Find Small Group Of ANA & RP Negative Patients

There exists a very small subgroup of patients with (SSc) who lack circulating (ANA) and who do not have Raynaud's phenomenon (RP), research shows. These patients also fail to meet any of the diagnostic criteria for known SSc mimics.The...

» UTHealth Scientists Closing In On Genes Tied To Scleroderma

A new study designed to test suspected links between genes and two immune disorders could open the door to better ways to diagnose and treat the conditions that affect a combined total of approximately 2.5 million people in the United States, report...

» Autoimmunity Versus Nutrition

Our immune system protects us from various diseases. However, at times it goes into an overdrive and attacks the body itself, leading to tissue destruction and degenerative diseases referred to as autoimmune diseases. Autoimmune disorders include...

» Positive Phase II Results for AIMSPRO In Scleroderma Announced

announced yesterday, positive results from its Double-Blind Placebo-Controlled Phase II Clinical Study evaluating the safety and tolerability of AIMSPRO given as a monotherapy to patients with Late Stage Established Diffuse Cutaneous Systemic...